A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
Citations Over TimeTop 10% of 2015 papers
Abstract
Post-mortem studies of neurological diseases are not ideal for identifying the underlying causes of disease initiation, as many diseases include a long period of disease progression prior to the onset of symptoms. Because fibroblasts from patients and healthy controls can be efficiently reprogrammed into human induced pluripotent stem cells (hiPSCs), and subsequently differentiated into neural progenitor cells (NPCs) and neurons for the study of these diseases, it is now possible to recapitulate the developmental events that occurred prior to symptom onset in patients. We present a method by which to efficiently differentiate hiPSCs into NPCs, which in addition to being capable of further differentiation into functional neurons, can also be robustly passaged, freeze-thawed or transitioned to grow as neurospheres, enabling rapid genetic screening to identify the molecular factors that impact cellular phenotypes including replication, migration, oxidative stress and/or apoptosis. Patient derived hiPSC NPCs are a unique platform, ideally suited for the empirical testing of the cellular or molecular consequences of manipulating gene expression.
Related Papers
- → Using the Neurosphere Assay to Quantify Neural Stem Cells In Vivo(2007)69 cited
- → The Neurosphere Assay Applied to Neural Stem Cells and Cancer Stem Cells(2013)21 cited
- → The Neurosphere Assay (NSA) Applied to Neural Stem Cells (NSCs) and Cancer Stem Cells (CSCs)(2019)9 cited
- Adenosine Promotes Proliferation of Neural Stem Cells in vitro(2008)
- Topiramate Promotes Proliferation of Neural Stem Cells in Vitro(2008)